Cause of death, by non-communicable diseases, ages 5-14, male in Ghana
Ghana: Cause of death, by non-communicable diseases, ages 5-14, male was 22.4% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, male in Ghana, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 5-14.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 5-14, male in Ghana is 22.4%, measured in 2021.
Compared with earlier readings it is down 4.7% on the previous year and up 15.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, male in Ghana peaked at 24.9% in 2019 and was at its lowest, 19.4%, in 2010.
Ghana ranks 138th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 5-14, male in Ghana, year by year
| Year | % of total male deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 20.5% | — |
| 2010 | 19.4% | -5.7% |
| 2015 | 23.7% | +22.4% |
| 2019 | 24.9% | +5.1% |
| 2020 | 23.5% | -5.7% |
| 2021 | 22.4% | -4.7% |
Ghana compared with similar countries
- Ghana's 22.4% is below the median for lower middle income countries, which is 23.6%, 95% of the median. (47 countries reporting)
- Ghana's 22.4% is above the median for Sub-Saharan Africa, which is 17.0%, 1.3× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 20.5% | 20.5% | 20.5% | 1 |
| 2010s | 22.7% | 19.4% | 24.9% | 3 |
| 2020s | 22.9% | 22.4% | 23.5% | 2 |
Countries ranked near Ghana
More health data for Ghana
- Un projection of annual infant deaths, annual growth rate -1.37 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6224 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 986.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,361 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 0.5623 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.06 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5816 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, male in Ghana?
- Cause of death, by non-communicable diseases, ages 5-14, male in Ghana was 22.4% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, male recorded in Ghana?
- The highest recorded value was 24.9% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, male recorded in Ghana?
- The lowest recorded value was 19.4% in 2010.
- How does Ghana rank for cause of death, by non-communicable diseases, ages 5-14, male?
- Ghana ranks 138th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, male rising or falling in Ghana?
- Over the last ten years it is up 15.6%. The long-run trend across the full record is rising.
- Where does this Ghana data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.